Skip to main content
. 2019 Dec 18;10:121. doi: 10.1186/s13244-019-0801-z

Fig. 21.

Fig. 21

a Axial T1-weighted MR in late arterial phase (AP) obtained pretreatment: image shows nonrim arterial phase hyperenhancement (APHE) of a 3-cm LR-5 observation in segments II-III (arrow). b Unenhanced axial CT obtained immediately post transarterial chemoembolization (TACE) of segment III: image shows suboptimal targeting with incomplete ethiodized oil retention (arrow). c Unenhanced axial CT obtained post repeat TACE: image shows extended treatment area with optimal targeting (arrow). Postcontrast imaging (not shown) did not show APHE or washout, the treated observation is categorized LR-TR Nonviable